FIELD: pharmaceutical chemistry. SUBSTANCE: invention provides serine protease inhibitors having piperidine side chain of general formula I: (I), wherein A is hydrogen atom, optionally substituted D, L-alpha-hydroxyacetyl, R1,R1-O-C(O)-,R1-SO2- and R2OOC-(CHR2)m-, in which R1 is selected from C1-C12-alkyl and C3-C8- cycloalkyl, indicated groups being optionally substituted by OH group, and C7-C15-arylalkyl; each group R2 independently denotes hydrogen atom or has the same denotations as indicated for R1; m=1,2 or 3; B denotes chemical bond, amino acid of formula -NH-CH[(CH2)pC(O)OH]-C(O)- with p=0,1,2, or 3, -N((1-12C)alkyl)-CH2-CO-, or D-1-Piq; or B represents D-amino acid having hydrophobic side chain; or A and B, taken together, represent group R3R4N-CHR5-C(O), in which R3 and R4 independently denote R1,R1-O-C(O)-,R1-C(O)-,R1-SO2- and R5 denotes hydrophobic or basic side chain; X represents L-amino acid with hydrophobic side chain; Y is CO-NH-C1-C6- alkylene-C6H5, -COOR6, in which R6 denotes hydrogen atom or C1-C6-alkyl, CONR7R8, in which R7 and R8, independent from each other, denote hydrogen atom or C1-C6- alkyl, or R7 and R8, taken together, represent C3-C6- alkylene; or Y denotes residue of heterocycle, selected from 2-thiazole, 2-benzothiazole, 20oxazole, or 2- benzoxazole; r = 0,1,2, or 3; or their pharmaceutically acceptable salts. Proposed compounds show anticoagulation activity and can be used for treating or preventing thrombin-caused diseases. Invention also provides pharmaceutical composition containing such inhibitor. EFFECT: increased assortment of anticoagulants. 15 cl, 2 tbl, 64 ex
Title |
Year |
Author |
Number |
SERINE PROTEASE INHIBITORS |
1997 |
- Anton Ehgbert Peter Adang
|
RU2178419C2 |
THROMBIN INHIBITORS |
1996 |
- Adang Anton Ehgbert Peter
- Van Bukkel' Konstant Adrian Anton
- Grotenkhjuis Peter Diderik Jan
- Peters Jakobus Al'Bertus Marija
|
RU2178796C2 |
INHIBITORS OF SERINE PROTEASE |
1997 |
- Grotenkhejs Peter Diderik Jan
- De Man Adrianus Petrus Antonius
- Adang Anton Ehgbert Peter
|
RU2191193C2 |
DERIVATIVES OF IMIDAZO-[1,5-A]-PYRIDINE AS INHIBITORS OF SERINE PROTEASES AND PHARMACEUTICAL COMPOSITION |
1996 |
- Khenrikus Karl Jozef Ottenkhejm
- Anton Ehgbert Peter Adang
- Jakobus Al'Bertus Marija Peters
|
RU2175327C2 |
INHIBITORS OF SERINE PROTEASES |
1998 |
- Adang Anton Ehgbert Peter
|
RU2183642C2 |
PEPTIDE DERIVATIVES, THEIR STEREOISOMERS OR PHYSIOLOGICALLY ACCEPTABLE SALTS SHOWING ANTITHROMBOSIS, ANTICOAGULATING OR ANTI-INFLAMMATORY ACTIVITY, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF SUPPRESSION OF THROMBIN ACTIVITY, METHOD OF INHIBITION OF KININOGENASES ACTIVITY, USE OF COMPOUNDS AS PARENT SUBSTANCES FOR SYNTHESIS OF THROMBIN INHIBITOR |
1994 |
- Karl Tomas Antonsson
- Rut Ehl'Vju Bjulund
- Nil'S David Gustafsson
- Nil'S Olov Ingemar Nil'Sson
|
RU2142469C1 |
STEROID COMPOUND, METHODS OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION |
1998 |
|
RU2182153C2 |
FIVE-MEMBERED HETEROCYCLIC AMIDINES ELICITING PROPERTIES OF THROMBIN INHIBITORS, COMPOUNDS CONTAINING DERIVATIVES OF FIVE-MEMBERED HETEROCYCLIC AMIDINE AS COMPONENT OF INHIBITORS OF SERINE PROTEASES AND INTERMEDIATE COMPOUNDS |
1997 |
- Dorit Bauke
- Udo Lange
- Khel'Mut Mak
- Verner Zajts
- Tomas Tsirke
- Khans Vol'Fgang Kheffken
- Vil'Frid Khornberger
|
RU2175328C2 |
THROMBIN INHIBITORS AND INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS |
1995 |
- Bem Khans-Joakhim
- Kozer Shtefan
- Mak Khel'Mut
- Pfajffer Tomas
- Zajtts Verner
- Kheffken Khans Vol'Fgang
- Khornberger Vil'Frid
|
RU2172741C2 |
PEPTIDE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF THROMBIN INHIBITION IN MAMMAL |
1995 |
- Smit Dzheral'D Flojd
- Uili Majkl Robert
- Shakht Aaron Lejg
- Shuman Robert Teodor
|
RU2148585C1 |